Casonato A, Girolami A
Folia Haematol Int Mag Klin Morphol Blutforsch. 1986;113(5):670-84.
Von Willebrand factor (vWf) is the major component of the circulating factor VIII complex. The von Willebrand molecule includes factor VIII related antigen (VIIIR: Ag) which represents the molecular substrate of the von Willebrand activity expressed as Ristocetin cofactor (VIIIR:RCoF) activity. Several methods have been developed for VIIIR: Ag evaluation, among the first being the rocket-immunoelectrophoresis method of LAURELL. Radial immunodiffusion (MANCINI's method) was also used. Subsequently, radioimmunological assays, either as radioimmunoassay (RIA) or immunoradiometric assay (IRMA), were developed with improvements in sensitivity, so that levels of VIIIR: Ag lower than 0.1% of normal can be detected. More recently, an enzyme-linked immunosorbent assay (ELISA), characterized by the use of enzyme-conjugated antibody was proposed. This method shows a sensitivity similar to immunoradiometric methods but without using any dangerous reagent. Finally, a nephelometric method was proposed for factor VIII antigen evaluation. For a qualitative evaluation of von Willebrand factor crossed-immunoelectrophoresis and multimeric analysis can be used. In the first case, the use of precipiting antibodies against von Willebrand factor may demonstrate a peak with different characteristics related to the biochemical property of von Willebrand. Multimeric analysis in SDS-agarose gel electrophoresis followed by staining with labelled antifactor VIII antibodies gives information about different polymeric forms of circulating VIII/vW factor. Von Willebrand factor activity, expressed as its ability to induce platelet aggregation in the presence of the antibiotic Ristocetin, can be carried out using normal formalin fixed platelets, either with aggregometer or visual methods (glass slide test or tubes test and microtritation plate). The corrected evaluation of factor VIII complex by all these techniques together with the clotting activity assay allows a satisfactory study of factor VIII properties.
血管性血友病因子(vWf)是循环中因子VIII复合物的主要成分。血管性血友病分子包括因子VIII相关抗原(VIIIR: Ag),它代表了以瑞斯托霉素辅因子(VIIIR:RCoF)活性表示的血管性血友病活性的分子底物。已经开发了几种用于评估VIIIR: Ag的方法,其中最早的是劳雷尔的火箭免疫电泳法。也使用了放射免疫扩散法(曼西尼法)。随后,开发了放射免疫测定法,即放射免疫分析(RIA)或免疫放射分析(IRMA),其灵敏度有所提高,因此可以检测到低于正常水平0.1%的VIIIR: Ag。最近,有人提出了一种酶联免疫吸附测定法(ELISA),其特点是使用酶偶联抗体。该方法显示出与免疫放射分析方法相似的灵敏度,但不使用任何危险试剂。最后,有人提出了一种比浊法用于因子VIII抗原评估。对于血管性血友病因子的定性评估,可以使用交叉免疫电泳和多聚体分析。在第一种情况下,使用针对血管性血友病因子的沉淀抗体可能会显示出与血管性血友病的生化特性相关的具有不同特征的峰。在SDS-琼脂糖凝胶电泳中进行多聚体分析,然后用标记的抗因子VIII抗体染色,可以提供有关循环中VIII/vW因子不同聚合形式的信息。血管性血友病因子活性,以其在抗生素瑞斯托霉素存在下诱导血小板聚集的能力来表示,可以使用正常的福尔马林固定血小板,通过聚集仪或视觉方法(玻片试验或试管试验以及微量滴定板)进行测定。通过所有这些技术对因子VIII复合物进行校正评估以及凝血活性测定,可以对因子VIII的特性进行令人满意的研究。